BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 36206305)

  • 1. Markov state modelling reveals heterogeneous drug-inhibition mechanism of Calmodulin.
    Westerlund AM; Sridhar A; Dahl L; Andersson A; Bodnar AY; Delemotte L
    PLoS Comput Biol; 2022 Oct; 18(10):e1010583. PubMed ID: 36206305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allosteric effects of the antipsychotic drug trifluoperazine on the energetics of calcium binding by calmodulin.
    Feldkamp MD; O'Donnell SE; Yu L; Shea MA
    Proteins; 2010 Aug; 78(10):2265-82. PubMed ID: 20544963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opposing orientations of the anti-psychotic drug trifluoperazine selected by alternate conformations of M144 in calmodulin.
    Feldkamp MD; Gakhar L; Pandey N; Shea MA
    Proteins; 2015 May; 83(5):989-96. PubMed ID: 25694384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular dynamics simulation of the calmodulin-trifluoperazine complex in aqueous solution.
    Yamaotsu N; Suga M; Hirono S
    Biopolymers; 2001 Apr; 58(4):410-21. PubMed ID: 11180054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitor and peptide binding to calmodulin characterized by high pressure Fourier transform infrared spectroscopy and Förster resonance energy transfer.
    Cinar S; Czeslik C
    Biochim Biophys Acta Proteins Proteom; 2018; 1866(5-6):617-623. PubMed ID: 29555454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trifluoperazine regulation of calmodulin binding to Fas: a computational study.
    Pan D; Yan Q; Chen Y; McDonald JM; Song Y
    Proteins; 2011 Aug; 79(8):2543-56. PubMed ID: 21656570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trifluoperazine binding to porcine brain calmodulin and skeletal muscle troponin C.
    Massom L; Lee H; Jarrett HW
    Biochemistry; 1990 Jan; 29(3):671-81. PubMed ID: 2110826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of trifluoperazine with Tetrahymena calmodulin. A 19F NMR study.
    Shimizu T; Hatano M; Muto Y; Nozawa Y
    FEBS Lett; 1984 Jan; 166(2):373-7. PubMed ID: 6420195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calmodulin antagonists enhance calcium binding to calmodulin.
    Inagaki M; Tanaka T; Hidaka H
    Pharmacology; 1983; 27(3):125-9. PubMed ID: 6622516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A high pressure study of calmodulin-ligand interactions using small-angle X-ray and elastic incoherent neutron scattering.
    Cinar S; Al-Ayoubi S; Sternemann C; Peters J; Winter R; Czeslik C
    Phys Chem Chem Phys; 2018 Jan; 20(5):3514-3522. PubMed ID: 29336441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ca2+-bound calmodulin forms a compact globular structure on binding four trifluoperazine molecules in solution.
    Matsushima N; Hayashi N; Jinbo Y; Izumi Y
    Biochem J; 2000 Apr; 347 Pt 1(Pt 1):211-5. PubMed ID: 10727421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium transport by sarcoplasmic reticulum of vascular smooth muscle: II. Effects of calmodulin and calmodulin inhibitors.
    Stout MA; Silver PJ
    J Cell Physiol; 1992 Oct; 153(1):169-75. PubMed ID: 1522130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of trifluoperazine with porcine calmodulin 19F NMR and induced CD spectral studies.
    Shimizu T; Hatano M
    FEBS Lett; 1983 Aug; 160(1-2):182-6. PubMed ID: 6411490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trifluoperazine binding to calmodulin: a shift reagent 43CA NMR study.
    Vogel HJ; Andersson T; Braunlin WH; Drakenberg T; Forsén S
    Biochem Biophys Res Commun; 1984 Aug; 122(3):1350-6. PubMed ID: 6477566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trifluoperazine-induced conformational change in Ca(2+)-calmodulin.
    Vandonselaar M; Hickie RA; Quail JW; Delbaere LT
    Nat Struct Biol; 1994 Nov; 1(11):795-801. PubMed ID: 7634090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metal ion and drug binding to proteolytic fragments of calmodulin: proteolytic, cadmium-113, and proton nuclear magnetic resonance studies.
    Thulin E; Andersson A; Drakenberg T; Forsén S; Vogel HJ
    Biochemistry; 1984 Apr; 23(8):1862-70. PubMed ID: 6722127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trifluoperazine binding to mutant calmodulins.
    Massom LR; Lukas TJ; Persechini A; Kretsinger RH; Watterson DM; Jarrett HW
    Biochemistry; 1991 Jan; 30(3):663-7. PubMed ID: 1988054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trifluoperazine, a Well-Known Antipsychotic, Inhibits Glioblastoma Invasion by Binding to Calmodulin and Disinhibiting Calcium Release Channel IP3R.
    Kang S; Hong J; Lee JM; Moon HE; Jeon B; Choi J; Yoon NA; Paek SH; Roh EJ; Lee CJ; Kang SS
    Mol Cancer Ther; 2017 Jan; 16(1):217-227. PubMed ID: 28062709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of trifluoperazine on calcium binding by calmodulin. A microcalorimetric study.
    Tanokura M; Yamada K
    J Biol Chem; 1985 Jul; 260(15):8680-2. PubMed ID: 4019446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complexes formed between calmodulin and the antagonists J-8 and TFP in solution.
    Craven CJ; Whitehead B; Jones SK; Thulin E; Blackburn GM; Waltho JP
    Biochemistry; 1996 Aug; 35(32):10287-99. PubMed ID: 8756684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.